Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: JPEN J Parenter Enteral Nutr. 2018 Apr 27;42(8):1238–1251. doi: 10.1002/jpen.1167

Figure 2.

Figure 2

Chenodeoxycholic acid (CDCA) activity: relative farnesoid X receptor (FXR) mRNA expression in HepG2 cells treated with CDCA. Box and whisker plots are shown. Boxes represent the 25th–75th percentile, and central lines represent median values. A Mann-Whitney U test was conducted to determine P-value. All tests were 2-sided using a significance level of 0.05. Note that there was significant upregulation of FXR with CDCA.